not losing weight tirzepatide Why am I on tirzepatide? Every reason and how to fix it Why Am I Not Losing

A New Indication for Semaglutide (Wegovy) The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease (CVD) and either obesity or overweight

Symptoms may include: Widespread hives Facial or lip swelling Breathing difficulty These symptoms are not typical of a standard weight loss injection Wegovy, and require immediate medical assessment

Weight reduction outcomes are often noticeable after a few months of adherenceespecially when paired with dietary changes

Weight Loss Efficacy: advantage goes to CagriSema